• Evonik expects full-year 2026 adjusted EBITDA in the upper half of its €2 billion–€2.2 billion guidance range.
• Return on capital employed is now forecast above 8%, versus previous guidance for a slight increase from 2025's 6.1%.
• Free cash flow guidance remains about €850 million, implying a cash conversion rate of about 40%.
• Third-quarter adjusted EBITDA rose 40% year over year to €629 million, supported by higher prices and volumes.
• Nine-month free cash flow more than doubled to €601 million, helping reduce total leverage to 2.1 times at September-end.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.